N/A
N=25
Feasibility of an Early Detection Program for Early Psychosis on a College Campus
Psychosis · First Episode Psychosis · Clinical High Risk for Psychosis
Bottom Line
View on ClinicalTrials.gov: NCT03983421 ↗Enrolled (actual)
25
Serious AEs
0.0%
Results posted
Apr 2024
Primary outcome: Primary: Duration of Untreated Psychosis
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- —
- Age
- Pediatric, Adult · 15+ yrs
- Sex
- All
- Sponsor
- University of New Mexico
- Primary completion
- Dec 2022
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Duration of Untreated Psychosis |
— | — |
| SECONDARY Number of Steps to Coordinated Specialty Care |
5.71 | — |
| SECONDARY Perceived Barriers to Seeking Psychological Help |
2.58; 2.68; 2.70; 2.57; 2.39; 2.51 | — |
Summary
The objective of the proposed study is to determine the feasibility of an Early Detection program that aims to: (i) identify college students at clinical high risk (CHR) of psychosis or with first episode psychosis (FEP), and (ii) efficiently link them to coordinated specialty care (CSC) services for a 2nd stage screen, a clinical assessment, and appropriate treatment. The study will also determine pathways to care and perceived barriers to care among those students enrolled in Coordinated Specialty Care.
Eligibility Criteria
Inclusion Criteria
- 15-30 year-old college students who present to the University of New Mexico (UNM) Early Program or the UNM CONNECT program for an intake,
- screen positive for clinical high risk on the Structured Interview for Prodromal Syndromes (SIPS) or first episode psychosis on the Structured Clinical Interview for Diagnostic Statistical Manual IV
- agree to participate in the study.
Exclusion Criteria
- below the age of 15 years old or above the age of 30,
- not UNM college students,
- screen negative for clinical high risk or first episode psychosis,
- refuse to participate in the study,
- cognitively unable to provide informed consent as demonstrated by a brief cognitive screen prior to completion of the enrollment interview
Data sourced from ClinicalTrials.gov (NCT03983421). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.